This is a preview of subscription content, log in via an institution to check access.
References
Morgan EP, Williams CN. Complete response of severe, refractory, gastric, stomal and sclerotherapy-induced esophageal ulcer disease to omeprazole therapy. Can J Gastroenterol 1989;3:179–181.
Gimson A, Poison R, Westaby D, Williams R. Omeprazole in the management of intractable esophageal ulceration following injection sclerotherapy. Gastroenterology 1990;99:1829–1831.
Johlin FC, Labrecque DR, Neil GA. Omeprazole in the healing and prevention of endoscopic injection sclerotherapy-associated mucosal ulcers. Gastroenterology 1991;100:A756.
Klinkenberg-Knol E, Janesen J, Festen H, et al. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux esophagitis. Lancet 1987;I:349–351.
Havelund T, Lauren L, Skoubo-Krestensen E, et al. Omeprazole and ranitidine in the treatment of reflux esophagitis; double-blind trial. Br Med J 1988;296:89–92.
Jaspersen D, Koerner T, Schwacha H, et al. Endoscopic bougienage of esophageal and anastomosis stenoses. Endosc Today 1992;256–261.
Jaspersen D, Koerner T, Hammar CH. Omeprazole in the management of H2 blocker-resistant sclerotherapy-induced esophageal ulcers. Dtsch Med Wochenschr 1993;188:685.
Jaspersen D, Koerner T, Schorr W, Hammar CH. Omeprazole in the management of H2 blocker-resistant esophageal ulcers following injection sclerotherapy. Endosc Today 1993;2:46–50.
Kitano S, Koyanagi N, Iso Y, et al. Prevention of recurrence of esophageal varices after endoscopie injection sclerotherapy with ethanolamine oleate. Hepatology 1987;7:810–815.
Gibbert V, Feinstat T, Turns M. A comparison of sclerosing agents sodium tetradecyl and sodium morrhuate in endoscopic injection sclerosis of esophageal varices (abstract). Gastrointest Endosc 1982;281:174.
Westaby D, Melia W, Macdougall BRD, et al. Injection sclerotherapy for esophageal varices: A prospective randomised trial of different treatment schedules. Gut 1984;25:129–132.
Soderlund C, Ihre T. Endoscopic sclerotherapy versus conservative management of bleeding esophageal varices. Acta Chir Scand 1987;151:449–456.
Westaby D, Macdougall BRD, Williams R. Improved survival following injection sclerotherapy for esophageal varices. Final analysis of a controlled trial. Hepatology 1985;5:827–830.
Roark G. Treatment of post-sclerotherapy esophageal ulcers with sucralfate. Gastrointest Endosc 1984;39:9–10.
Reilly J, Schadl R, Van Thiel D. Esophageal function after injection sclerotherapy; pathogenesis of esophageal stricture. Ann Surg 1984;147:85–88.
Bretagne JF, Gosselin A, Le Jean-Colin I, et al. Structure and function of the esophagus after endoscopie variceal sclerotherapy in cirrhotic patients. Gastroenterol Clin Biol 1987;11:48–55.
Snady H, Korsten M. Esophageal acid clearance and motility after endoscopic sclerotherapy of esophageal varices. Am J Gastroenterol 1986;81:419–422.
Sauerbruch T, Worschung R, Holl J, et al. Effects of repeated injection sclerotherapy on acid gastroesophageal reflux. Gastrointest Endosc 1986;32:81–83.
Gustavsson S, Adami HO, Lööf L. Rapid healing of duodenal ulcers with omeprazole: Double-blind, dose-comparative trial. Lancet 1983;II:124–125.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jaspersen, D., Körner, T., Schorr, W. et al. Omeprazole in the management of sclerotherapy-induced esophageal ulcers resistant to H2 blocker treatment. J Gastroenterol 30, 128–130 (1995). https://doi.org/10.1007/BF01211388
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01211388